Journals / Retina-Vitreus / 2006 / Cilt: 14 - Sayı: 4

Pseudomonas aeruginosa endophthalmitis following intravitreal triamcinolone injection

İntravitreal triamsionolon enjeksiyonu sonrasında psödomonas aeruginosa endoftalmisi

Pages
311–313
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that the procedure should be performed under totally sterile conditions and the eye should be padded for a day to prevent such a dreadful complication.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We describe a case of early pseudomonas aeruginosa-endophthalmitis following intravitreal triamcinolone injection for the treatment of diabetic macular edema refractory to grid laser photocoagulation.
📊
Key Findings & Data:The eye had to be eviscerated in spite of early treatment with intravitreal antibiotics to which the organism is sensitive.
💡
Conclusion & Impact:We suggest that the procedure should be performed under totally sterile conditions and the eye should be padded for a day to prevent such a dreadful complication.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We describe a case of early pseudomonas aeruginosa-endophthalmitis following intravitreal triamcinolone injection for the treatment of diabetic macular edema refractory to grid laser photocoagulation. The eye had to be eviscerated in spite of early treatment with intravitreal antibiotics to which the organism is sensitive. We suggest that the procedure should be performed under totally sterile conditions and the eye should be padded for a day to prevent such a dreadful complication.

Özet

Bu çalışmada grid laser fotokoagülasyona dirençli diabetik makula ödemi olan bir olguya uygulanan intravitreal triamsinolon enjeksiyonu sonrasında erken dönemde gelişen psödomonas aeruginosa endoftalmisi tartışılmaktadır. Erken dönemde psödomonas aeruginosa’nın duyarlı olduğu intravitreal antibiotik uygulamasına rağmen klinik iyileşme saptanmamış olup, sonuçta evisserasyon gerçekleştirilmiştir. Sonuç olarak mümkünse intravitreal triamsinolon uygulamasının tam steril koşullarda yapılması ve uygulama sonrasında gözün bir gün süreyle kapatılmasının bu kötü komplikasyonu engellemede etkili olabileceği düşünülmüştür.

🔖

Cite This Article

DİNÇ, U. A., ÖZDEK, Ş., GÜRELİK, G., HASANREİSOĞLU, B. (2006). Pseudomonas aeruginosa endophthalmitis following intravitreal triamcinolone injection. Retina-Vitreus, Cilt: 14 - Sayı: 4, 311–313. https://ajindex.com/articles/305268

References (16)

  1. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group: Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103:1796-1806
  2. Mcdonald HR, Schatz H.: Grid photocoagulation for diffuse macular edema. Retina. 1985;5:65-72
  3. Jonas JB, Kreissig I, Söfker A, et al.: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;121:57-61
  4. Martidis A, Duker J, Greenberg F) et al.: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927
  5. Wilson CA, Berkowtiz BA, Sato T, et al.: Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophtalmol. 1992;110:1115-111 9
  6. Moshfeghi DM, Kaiser PK, Scott III, et al.: Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136:791-796
  7. Nelson ML, Tennant MT, Sivalingam A, et al.: Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23:686-691
  8. Jonas JB. Intravitreal triamcinolone acetonide: A change in paradigm. Ophthalmic Res. 2006;38:218-245
  9. Roth DB, Chieh J, Spirn MJ, et al.: Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003;121:1279-1282
  10. Sutter FK, Gillies MC.: Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003;87:972-974
  11. Benz MS, Murray TG, Dubovy SR, et al.: Endophthalmitis caused by Mycobacterium chelonae after intravitreal injection of triamcinolone. Arch Ophthalmol. 2003:121;271-273
  12. Eifrig CW, Scott III, Flynn HW Jr, et al.: Endophthalmitis caused by Pseudomonas aeruginosa. Br J Ophthalmol. 2003;110:1714-1717
  13. Jonas JB, Kreissig I, Degenring RF.: Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol. 2003;121:1663-1664
  14. Eifrig CW, Flynn HW Jr, Scott IU, et al.: Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002;33:373-378
  15. Heineman MH.: Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1989; 107:1 767-1772
  16. Jonas JB, Kreissig I, Spandau UH, et al.: Infectious and non-infe-ctious endophthalmitis after intravitreal high-dose triamcinolone acetonide. Am J Ophthalmol. 2006;141:579-580.